Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II

Circulation

Volumn 112, Issue 2, 2005, Pages 257-263

  Matsui, Reiko ^a,b   Xu, Shanqin ^a   Maitland, Karlene A ^a   Hayes, Antoinette ^a   Leopold, Jane A ^a   Handy, Diane E ^a   Loscalzo, Joseph ^a   Cohen, Richard A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiotensin; Aorta; Free radicals; Hypertension; Hypertrophy

Indexed keywords

3 NITROTYROSINE; ANGIOTENSIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDROETHIDINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMIZYGOTE; HYPERTENSION; MALE; MOUSE; MUSCLE HYPERTROPHY; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN II; ANIMALS; AORTA; BLOOD VESSELS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HYPERTENSION; HYPERTROPHY; MALE; MICE; MICE, MUTANT STRAINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SUPEROXIDES;

EID: 22144461029     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.499095     Document Type: Article

References (50)

1. Salvemini F, Franze A, Iervolino A, Filosa S, Salzano S, Ursini MV. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J Biol Chem. 1999;274: 2750-2757.
2. Leopold JA, Loscalzo J. Cyclic strain modulates resistance to oxidant stress by increasing G6PD expression in smooth muscle cells. Am J Physiol. 2000;279:H2477-H2485.
3. Tsai KJ, Hung IJ, Chow CK, Stern A, Chao SS, Chiu DTY. Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phophate-dehydrogenase-deficient granulocytes. FEBS Lett. 1998;436: 411-414.
4. Hothersall JS, Gordge M, Noronha-Dutra AA. Inhibition of NADPH supply by 6-aminonicotinamide: effect on glutathione, nitric oxide, and superoxide in J774 cells. FEBS Lett. 1998;434:97-100.
5. Guo L, Zhang Z, Green K, Stanton RC. Suppression of interleukin-1β- induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase. Biochemistry. 2002;41:14726-14733.
6. Leopold JA, Zhang YY, Scribner AW, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler Thromb Vasc Biol. 2003;23:411-417.
7. Pascale R, Garcea R, Ruggiu ME, Daino L, Frassetto S, Vannini MG. Cozzolino P, Lenzerni L, Feo F, Schwartz AG. Decreased stimulation by 12-0-tetradecanoylphorbol-13-acetate of superoxide radical production by polymorphonuclear leukocytes carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. Carcinogenesis. 1987;8:1567-1570.
8. Gupte SA, Arshad M, Viola S, Kaminski PM, Ungvari Z, Rabbani G, Koller A, Wolin MS. Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries. Am J Physiol. 2003;285:H2316-H2326.
9. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul. Pept. 2000;91:21-27.
10. Lassegue B, Clempus RE. Vascular NAD(P)H oxidase: specific features, expression, and regulation. Am J Physiol. 2003;285:R277-R297.
11. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
12. phox in aortas from angiotensin II-infused mice. Am J Physiol. 2000;279:H2234-H2240.
13. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn M, Pagano O, Schffrin RL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries. Circ Res. 2002;90:1205-1213.
14. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271: 23317-23321.
15. 3 in angiotensin II-induced vascular hypertrophy. Hypertension. 1998;32:488-495.
16. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediates the activation of Akt/ protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem. 1999;274:22699-22704.
17. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38MAP kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II: role in vascular smooth muscle cell hypertrophy. J Biol Chem. 1998;273:15022-15029.
18. Rocic P, Seshiah P, Griendling KK. Reactive oxygen species sensitivity of angiotensin II-dependent translation initiation in vascular smooth muscle cells. J Biol Chem. 2003;278:36973-36979.
19. Adachi T, Pimentel DR, Heibeck T, Hou X, Lee YJ, Jiang B, Ido Y, Cohen RA. S-glutathiolation of ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem. 2004;279: 29857-29862.
20. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res. 2001;88:947-953.
21. phox in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40:511-515.
22. Wiesenfeld SL, Petrakis NL, Sams BJ, Collen MF, Culler JL. Elevated blood pressure, pulse rate, and serum creatinine in Negro males deficient in glucose-6-phosphate dehydrogenase. N Engl J Med. 1970;282: 1001-1002.
23. Leopold JA, Walker J, Scribner AW, Voetsch B, Zhang YY, Loscalzo AJ, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J Biol Chem. 2003;278:32100-32106.
24. Preisen w, Charles DJ, Merkle S. X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus. Biochem Genet. 1988;26:89-103.
25. Sanders S, Smith DP, Thomas GA, Williams ED. A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiency. Mutat Res. 1997;374:79-87.
26. Jain M, Cui L, Brenner DA, Wang B, Handy DE, Leopold JA, Loscalzo J, Apstein CS, Liao R. Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation. 2004;109:898-903.
27. Wang HD, Johns DG, Xu S, Cohen R. Role of superoxide anion in regulaling pressor and vascular hypertrophic response to angiotensin II. Am J Physiol. 2002;282:H1697-H1702.
28. Johns C, Gavras I, Handy DE, Salomao A, Gavras H. Models of experimental hypertension in mice. Hypertension. 1996;28:1064-1069.
29. Miller FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Cir Res. 1998; 82:1298-1305,
30. Stanton RC, Seifter JL, Boxer DC, Zimmerman E, Cantley LC. Rapid release of bound glucose-6-phosphate dehydrogenase by growth factors. J Biol Chem. 1991;266:12442-12448.
31. Zhang Z, Yu J, Stanton RC. A method for determination of pyridine nucleotides using a single extract. Anal Biochem. 2000;285:163-167.
32. Umeki S. Prostaglandin E1 and analogs of prostacyclin influencing superoxide production by the human neutrophil NADPH oxidase system. Int J Biochem. 1994;26:1003-1008.
33. Miller F, Griendling KK. Functional evaluation of nonphagocytic NAD(P)H oxidases. Methods Enzymol. 2002;353:220-233.
34. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA. 1991;88:7773-7777.
35. Wolff DJ, Datto GA. Identification and characterization of a calmodulin-dependent nitric oxide synthase from GH3 pituitary cells. Biochem J. 1992;285:201-206.
36. Worthington DJ, Rosemeyer MA. Glutathione reductase from human erythrocytes: catalytic properties and aggregation. Eur J Biochem. 1976; 67:231-238.
37. Wang HD, Hope S, Du Y, Quinn MT, Cayatte A, Pagano PJ, Cohen RA. Paracrine role of adventitial superoxide anion in mediation spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension. 1999;33:1225-1232.
38. Sorescu D, Somers MJ, Lassegue B, Grant S, Harrison DG, Griendling KK. Electron spin resonance characterization of NAD(P)H oxidase in vascular smooth muscle cells. Free Radic Biol Med. 2001;30:603-612.
39. Souza H, Liu X, Samouilov A, Kuppusamy P, Laurindo FRM, Zweier JL. Quantitation of superoxide generation and substrated utilization by vascular NAD(P)H oxidase. Am J Physiol. 2002;282:H466-H474.
40. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol. 1995;268:H2274-H2280.
41. Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, Ahmad M, Edwards J, Wolin MS. Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Phyiol. 2005;288:H13-H21.
42. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK. Hamson DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Inves. 1996;97:1916-1923.
43. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamaguchi-Takihara K, Harada M, Saito Y, Ogawa S. ERK and p38MAPK, but not NF-κB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res. 2001;89:661-669.
44. Frank GD, Eguchi S, Yamakawa T, Tanaka S, Inagami T, Motley ED. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology. 2000;141:3120-3126.
45. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105:1605-1612.
46. Weiss D, Kools JJ, Taylor R. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoE-deficient mice. Circulation. 2001;103:448-454.
47. Tamarat R, Silvestre JS, Kubis N, Benessiano J, Duriez M, deGasparo M, Henrion D, Levy BT. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension. 2002;39:830-835.
48. Matsui R, Maitland KA, Xu S, Goldstein GH, Handy DE, Cohen RA. G6PD deficiency reduces serum cholesterol and atherosclerosis in ApoE deficient mice. Circulation. 2003;108:IV-78. Abstract.
49. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, Newbold CI, Greenwood BM, Marsh K, Hill AVS. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 1995;376:246-249.
50. Cocco P, Todde P, Fornera S, Manca MB, Manca P, Sias AR. Mortality in a cohort of men expressing the glucose-6-phophate dehydrogenase deficiency. Blood. 1998;91:706-709.